BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRCA1
,
T cell differentiation
,
Lung cancer
,
Neuron
,
Metabolism of nitric oxide
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
disease chronic myeloid leukemia
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
GAS2
MAN1A1
CXCR4
TPSAB1
AQP9
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
PUJANA_BRCA1_PCC_NETWORK
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
PUJANA_CHEK2_PCC_NETWORK
CAIRO_HEPATOBLASTOMA_CLASSES_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Gene expression of CML CD34+ cells during imatinib therapy
Goat model for chronic myelogenous leukemia
AML-like or not AML-like bone marrow and PBMC subsets from juvenile myelomonocytic leukemia patients
GSK cancer cell line transcript profiling
Effects of BCR-ABL expression in long-term repopulating hematopoietic stem cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Chronic myeloid leukemia: a type of MPN.
CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases.
Bleeding Diathesis as the Initial Presentation of Chronic Myeloid Leukemia: A Case Series.
Recent progress in the management of pediatric chronic myeloid leukemia.
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease
Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease Whi…
RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ